
07/14/2023
TheracosBio will charge $47.85 plus shipping and handling for a 30-day supply of the SGLT2i bexagliflozin
TheracosBio teams with Mark Cuban's Cost Plus to launch Brenzavvy at bargain price
As another SGLT2 diabetes drug hits the market, the obvious question is: How will it find a way to compete against formidable blockbusters Farxiga and Jardiance? | TheracosBio and Mark Cuban's online distributor Cost Plus Drug Company have partnered to provide newly approved SGLT2 inhibitor Brenzavv...